Now showing items 1-1 of 1
Formulation development of a novel antivirulence compound for enhanced pharmocokinetic properties
(University of Missouri--Columbia, 2019)
[ACCESS RESTRICTED TO THE UNIVERSITY OF MISSOURI AT REQUEST OF AUTHOR.] A novel antivirulence compound CCG-211790 (termed as C790 in this context), has demonstrated significant inhibition against several severe ...